Charles River Laboratories International Inc

NYSE:CRLHealthcareCBOE:SPESGNASDAQ:NQUSMG

$300.02−0.04%At closeAt close · Tue 20 Oct · ≈ AED 1,101.82 · Market cap $14.32B · Next earnings Wed 4 Nov

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	0.2	0.2	0.2	0.3	0.2	0.2	+9.8%
Cash & short-term investments	0.2	0.2	0.2	0.3	0.2	0.2	+9.8%
Receivables	0.6	0.7	0.8	0.8	0.7	0.7	−1.7%
Inventory	0.2	0.2	0.3	0.4	0.3	0.3	+7.4%
Total current assets	1.2	1.3	1.4	1.6	1.4	1.4	+3.1%
Property, plant & equipment	1.3	1.6	1.9	2.0	2.0	2.0	+0.0%
Goodwill & intangibles	2.6	3.8	3.8	4.0	3.6	3.1	−13.0%
Long-term investments	0.2	0.2	0.3	0.2	0.2	0.2	−5.2%
Total assets	5.5	7.0	7.6	8.2	7.5	7.1	−5.2%
Payables	0.1	0.2	0.2	0.2	0.1	0.1	+6.0%
Short-term debt	0.0	0.0	0.0	0.0	0.0	0.1	—
Total current liabilities	0.8	1.0	1.1	1.1	1.0	1.1	+12.7%
Long-term debt	1.9	2.9	2.7	2.6	2.2	2.5	+13.6%
Total debt	2.2	3.2	3.1	3.1	2.7	3.1	+12.5%
Net debt	1.9	3.0	2.9	2.8	2.5	2.9	+12.7%
Deferred revenue	0.3	0.2	0.3	0.2	0.2	0.2	−15.3%
Total liabilities	3.3	4.4	4.6	4.5	4.0	3.9	−2.4%
Total equity	2.1	2.5	3.0	3.6	3.5	3.2	−8.6%
Retained earnings	0.6	1.0	1.4	1.9	1.8	1.4	−23.4%

USD billionsUpdated Wed 5 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.